VanWorld Pharmaceutical (Rugao) Company Limited   Report issue

For profit Phase 3
Founded: Jiangsu China (2005)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2005
NCT02633618
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

naproxen (naprosyn) (2 trials)

neurotropin (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 3)

Low Back Pain (Phase 3)

Neuralgia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2